These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas. Scatton B; Bartholini G J Pharmacol Exp Ther; 1982 Mar; 220(3):689-95. PubMed ID: 6278131 [No Abstract] [Full Text] [Related]
43. Neurotransmitter phenotypes of intermediate zone reticular formation projections to the motor trigeminal and hypoglossal nuclei in the rat. Travers JB; Yoo JE; Chandran R; Herman K; Travers SP J Comp Neurol; 2005 Jul; 488(1):28-47. PubMed ID: 15912497 [TBL] [Abstract][Full Text] [Related]
44. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Miczek KA; Fish EW; De Bold JF; De Almeida RM Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445 [TBL] [Abstract][Full Text] [Related]
46. [Neurotransmitters and epilepsy. The antiepileptic effect of biogenic amines gamma-aminobutyric-acid and taurine in patients with epilepsy (author's transl)]. Schmidt D Nervenarzt; 1980 Oct; 51(10):582-90. PubMed ID: 6109260 [No Abstract] [Full Text] [Related]
47. [Neurochemistry of convulsiveness. Some neurobiological mechanisms of experimental and human epilepsy]. Buscaino GA; Striano S Acta Neurol (Napoli); 1976; 31(4):413-23. PubMed ID: 16440 [No Abstract] [Full Text] [Related]
48. Neurobiology of aging. Norstrand IF N Y State J Med; 1981 May; 81(6):956-64. PubMed ID: 6112724 [No Abstract] [Full Text] [Related]
49. Receptors and the mechanism of action of ECT. Lerer B; Belmaker RH Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347 [No Abstract] [Full Text] [Related]
50. Changes in the function of the inhibitory neurotransmitter system in the rat brain following subchronic inhalation exposure to 1-bromopropane. Ueno S; Yoshida Y; Fueta Y; Ishidao T; Liu J; Kunugita N; Yanagihara N; Hori H Neurotoxicology; 2007 Mar; 28(2):415-20. PubMed ID: 16647755 [TBL] [Abstract][Full Text] [Related]
52. Neuroscience. Vehicles of inactivation. Snyder SH Nature; 1991 Nov; 354(6350):187. PubMed ID: 1683684 [No Abstract] [Full Text] [Related]
53. Neuropharmacology of depression, anxiety, and pain. King RB Clin Neurosurg; 1981; 28():116-36. PubMed ID: 6119174 [No Abstract] [Full Text] [Related]
54. [Neuromediators in the brain of the aged]. Kopp N; Tommasi M Presse Med; 1983 Dec; 12(48):3103-7. PubMed ID: 6140675 [TBL] [Abstract][Full Text] [Related]
55. Alterations in neurotransmitter activity after acute and chronic ethanol treatment: studies of transmitter interactions. Hunt WA; Majchrowicz E; Dalton TK; Swartzwelder HS; Wixon H Alcohol Clin Exp Res; 1979 Oct; 3(4):359-63. PubMed ID: 42321 [TBL] [Abstract][Full Text] [Related]
56. γ-aminobutyric acid as a metabolite: Interpreting magnetic resonance spectroscopy experiments. Myers JF; Nutt DJ; Lingford-Hughes AR J Psychopharmacol; 2016 May; 30(5):422-7. PubMed ID: 27005308 [TBL] [Abstract][Full Text] [Related]
57. The measurement of acetylcholine turnover rate in brain structures. Racagni G; Cheney DL; Zsilla G; Costa E Neuropharmacology; 1976 Dec; 15(12):723-36. PubMed ID: 796753 [No Abstract] [Full Text] [Related]
58. [Pain and chemical transmitters]. Otsuka M Rinsho Shinkeigaku; 1988 Dec; 28(12):1367-9. PubMed ID: 2474400 [No Abstract] [Full Text] [Related]
59. Neurotransmitter receptors and aging. Severson JA J Am Geriatr Soc; 1984 Jan; 32(1):24-7. PubMed ID: 6317731 [TBL] [Abstract][Full Text] [Related]
60. Molecules Affecting Brain Development and Nervous System. Nakadate K; Kawakami K Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]